Brain Cancer
CNS Pharmaceuticals CEO Outlines Glioblastoma Treatment Strategy and Market Opportunities in Podcast Interview
CNS Pharmaceuticals CEO John Climaco discussed the company's progress in developing novel brain cancer treatments and expanding into aggressive cancers like triple-negative breast cancer with brain metastases during a recent BioMedWire podcast appearance.
Blocking Brain Damage from Glioblastoma May Slow Tumor Growth and Extend Cognitive Function
New research from University College London suggests that preventing brain damage caused by glioblastoma could significantly slow tumor progression and preserve cognitive function longer in patients.
Study Links Traumatic Brain Injuries to Increased Brain Cancer Risk in Veterans
A recent study published in JAMA Network reveals that military veterans with traumatic brain injuries face a significantly higher risk of developing brain cancer, highlighting the urgent need for advanced treatments and preventive measures.
Research Uncovers Early Development Patterns of Pediatric Brain Tumors
A new study explores the complex origins of medulloblastoma in specialized nerve cells, potentially offering insights for future treatment strategies in pediatric brain cancer.